{"url_path":"/sec/aidx/8-k/2026-07-01/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1139685/0001213900-26-074182-index.html","accession_number":"0001213900-26-074182","cik":"0001139685","ticker":"AIDX","issuer_name":"20/20 Biolabs, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1139685/0001213900-26-074182-index.html","primary_entity_key":"0001139685","primary_entity_name":"20/20 Biolabs, Inc."},"word_count":158,"has_tables":true,"body_markdown":"**Item\n7.01 Regulation FD Disclosure**\n\n \n\n20/20 Biolabs, Inc. (the “Company”)\nintends to use the materials attached to this report as Exhibit 99.1 in an investor webinar on July 1, 2026. The furnishing of\nthese materials is not intended to constitute a representation that such furnishing is required by Regulation FD or other securities\nlaws, or that the presentation materials include material investor information that is not otherwise publicly available. In addition,\nthe Company does not assume any obligation to update such information in the future.\n\n \n\nThe information in this report (including Exhibit\n99.1) is furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities\nExchange Act of 1934, as amended, or otherwise subject to the liabilities of such Section. The information in this report will not be\ndeemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation\nFD."}